- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02208687
Effectiveness and Cost-effectiveness of the Energetic Program
November 6, 2017 updated by: Radboud University Medical Center
Energetic, a Self Management Group Program Aimed at Reconditioning and Social Participation in Persons With a Muscle Disease; a Multicentre Randomized Controlled Trial.
Fatigue is present in at least 60% of the patients with a muscle disease and can be the most disabling symptom.
In combination with other impairments, this often results in low levels of physical activity and decreased social participation, leading to large societal costs.
Energetic is a self-management group program aimed at improving participation and physical endurance in these patients.
Our hypothesis is that Energetic results in improved participation and improved physical endurance, less experienced fatigue and better quality of life compared to usual care, without increasing health care costs.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
53
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gelderland
-
Nijmegen, Gelderland, Netherlands
- Radboudumc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- formal diagnosis of muscular disease, either FascioScapuloHumeral Dystrophy (FSHD), Inclusion Body Myositis (IBM), Mitochondrial Myopathy (MM) or any other;
- being severely fatigued
- being cardiopulmonary stable and capable of aerobic training (as determined using a submaximal cycling exercise test with ECG (electrocardiography) and advice from a consultant cardiologist and pulmonologist);
- being motivated, committed to the program, and 'ready to change' which is discussed with the patient during the screening by a rehabilitation physician and an occupational therapist; to this end, motivational interviewing will be used (including a advantages/disadvantages matrix; a visual analogue scale (VAS) to rate the importance of participation in de program; and a VAS to rate the confidence a patient has that participation in the program is feasible)
- being able to formulate at least 3 individual participation goals during the interview with the occupational therapist.
Exclusion Criteria:
- active depression or other psychiatric disorder as indicated by a consultant psychologist or by the medical history,
- pregnancy,
- severe co-morbid condition,
- having participated in the Energetic program before
- a travel distance perceived as too burdensome
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Energetic
Self management group program aimed at reconditioning and social participation
|
Physiotherapy and occupational therapy aimed at reconditioning and social participation.
|
|
Other: Control group
Usual care
|
Usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Canadian Occupational Performance Measure (COPM)
Time Frame: 3 months
|
Perceived activity performance.
Three months will be the primary analysis.
Effects at follow up will be measured at 6 and 12 months (see secondary outcome measures) (patient)
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Activity Card Sort (ACS)
Time Frame: 3 months
|
Participation measure:% retained activities.(patient)
|
3 months
|
|
Canadian Occupational Performance Measure (COPM-satisfaction)
Time Frame: 3 months
|
Perceived satisfaction with performance (patient)
|
3 months
|
|
Canadian Occupational Performance Measure (COPM-satisfaction)
Time Frame: 6 months
|
Perceived satisfaction with performance (patient)
|
6 months
|
|
Canadian Occupational Performance Measure (COPM-satisfaction)
Time Frame: 15 months
|
Perceived satisfaction with performance (patient)
|
15 months
|
|
Canadian Occupational Performance Measure (COPM-performance)
Time Frame: 6 months
|
Perceived performance in activities.
Is primary outcome measure at 3 months, but data of 6 and 15 months follow up wil be used in a secondary analysis.
(patient)
|
6 months
|
|
Canadian Occupational Performance Measure (COPM-performance)
Time Frame: 15 months
|
Perceived performance in activities.
Is primary outcome measure at 3 months, but data of 6 and 15 months follow up wil be used in a secondary analysis.
(patient)
|
15 months
|
|
Activity Card Sort (ACS)
Time Frame: 6 months
|
Participation measure:% retained activities.(patient)
|
6 months
|
|
Activity Card Sort (ACS)
Time Frame: 15 months
|
Participation measure:% retained activities.(patient)
|
15 months
|
|
Six Minutes Walking Test (6MWT)
Time Frame: 3 months
|
physical endurance, sub-max test.
(patient)
|
3 months
|
|
Six Minutes Walking Test (6MWT)
Time Frame: 6 months
|
physical endurance, sub-max test.
(patient)
|
6 months
|
|
Six Minutes Walking Test (6MWT)
Time Frame: 15 months
|
physical endurance, sub-max test.
(patient)
|
15 months
|
|
Health care cost
Time Frame: 3 months
|
Evaluation health care cost (patient)
|
3 months
|
|
Health care cost
Time Frame: 6 months
|
Evaluation health care cost (patient)
|
6 months
|
|
Health care cost
Time Frame: 15 months
|
Evaluation health care cost (patient)
|
15 months
|
|
Checklist Individual Strength subscale fatigue (CIS-fatigue)
Time Frame: 3 months
|
Impact of fatigue (patient)
|
3 months
|
|
Checklist Individual Strength subscale fatigue (CIS-fatigue)
Time Frame: 6 months
|
Impact of fatigue (patient)
|
6 months
|
|
Checklist Individual Strength subscale fatigue (CIS-fatigue)
Time Frame: 15 months
|
Impact of fatigue (patient)
|
15 months
|
|
Health-related Quality of Life: Short Form 36 (SF-36)
Time Frame: 3 months
|
Quality of life, used for evaluation of cost effectiveness (patient)
|
3 months
|
|
Health-related Quality of Life: Short Form 36 (SF-36)
Time Frame: 6 months
|
Quality of life, used for evaluation of cost effectiveness (patient)
|
6 months
|
|
Health-related Quality of Life: Short Form 36 (SF-36)
Time Frame: 15 months
|
Quality of life, used for evaluation of cost effectiveness (patient)
|
15 months
|
|
General Self-Efficacy Scale
Time Frame: 3 months
|
Evaluation of the perceived self-efficacy (patient)
|
3 months
|
|
General Self-Efficacy Scale
Time Frame: 6 months
|
Evaluation of the perceived self-efficacy (patient)
|
6 months
|
|
General Self-Efficacy Scale
Time Frame: 15 months
|
Evaluation of the perceived self-efficacy (patient)
|
15 months
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 3 months
|
Anxiety and depression (patient)
|
3 months
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 6 months
|
Anxiety and depression (patient)
|
6 months
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 15 months
|
Anxiety and depression (patient)
|
15 months
|
|
Zarit Burden Inventory (ZBI)
Time Frame: 3 months
|
Perceived caregiver burden (caregiver)
|
3 months
|
|
Zarit Burden Inventory (ZBI)
Time Frame: 6 months
|
Perceived caregiver burden (caregiver)
|
6 months
|
|
Zarit Burden Inventory (ZBI)
Time Frame: 15 months
|
Perceived caregiver burden (caregiver)
|
15 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Edith Cup, dr., Radboudumc, department Rehabilitation
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Veenhuizen Y, Satink T, Graff MJ, Geurts AC, Groothuis JT, van Engelen BG, Nijhuis-van der Sanden MW, Cup EH. Mixed methods evaluation of a self-management group programme for patients with neuromuscular disease and chronic fatigue. BMJ Open. 2021 Aug 25;11(8):e048890. doi: 10.1136/bmjopen-2021-048890.
- Veenhuizen Y, Cup EHC, Jonker MA, Voet NBM, van Keulen BJ, Maas DM, Heeren A, Groothuis JT, van Engelen BGM, Geurts ACH. Self-management program improves participation in patients with neuromuscular disease: A randomized controlled trial. Neurology. 2019 Oct 29;93(18):e1720-e1731. doi: 10.1212/WNL.0000000000008393. Epub 2019 Sep 30. Erratum In: Neurology. 2020 Mar 3;94(9):414.
- Veenhuizen Y, Cup EH, Groothuis JT, Hendriks JC, Adang EM, van Engelen BG, Geurts AC. Effectiveness and cost-effectiveness of a self-management group program to improve social participation in patients with neuromuscular disease and chronic fatigue: protocol of the Energetic study. BMC Neurol. 2015 Apr 19;15:58. doi: 10.1186/s12883-015-0314-4.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2014
Primary Completion (Actual)
November 1, 2016
Study Completion (Actual)
May 1, 2017
Study Registration Dates
First Submitted
August 4, 2014
First Submitted That Met QC Criteria
August 4, 2014
First Posted (Estimate)
August 5, 2014
Study Record Updates
Last Update Posted (Actual)
November 7, 2017
Last Update Submitted That Met QC Criteria
November 6, 2017
Last Verified
April 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014/077
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuromuscular Diseases
-
Virginia Commonwealth UniversityRecruitingNeuromuscular Diseases | Neuromuscular Disorder | Neuromuscular Diseases in ChildrenUnited States
-
Brugmann University HospitalCompletedAnesthesia, General | Neuromuscular Transmission DisordersBelgium
-
University Hospital, ToursCompletedNeuromuscular Diseases in Children | Neuromuscular Diseases in InfantsFrance
-
Northwestern UniversityRecruiting
-
Ankara City Hospital BilkentNot yet recruitingNeuromuscular Blockade | Neuromuscular Monitoring | Statin-Associated Myopathy
-
MarsiBionicsHospital Universitario La PazNot yet recruitingNeuromuscular DisordersSpain
-
Ottawa Hospital Research InstituteEnrolling by invitation
-
University of FloridaTerminated
-
Penwest Pharmaceuticals Co.TerminatedNeuromuscular DiseaseUnited Kingdom
Clinical Trials on Control group
-
Tasly Pharmaceutical Group Co., LtdCompleted
-
Chengdu Sport UniversityNot yet recruiting
-
Hanlim Pharm. Co., Ltd.Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
International University of La RiojaCompletedPsychosis | Therapy | PsychologicalSpain
-
The University of Hong Konghong Kong Cancer FundCompletedBreast Cancer | Yoga Therapy | Shoulder Joint Motion | Scar Contracture
-
The First Affiliated Hospital of Zhejiang Chinese...Not yet recruitingAdolescent Idiopathic ScoliosisChina
-
Romanian Society of Anesthesia and Intensive CareUniversity of Medicine and Pharmacy "Victor Babes" Timisoara; Timişoara County...Completed
-
University of MaltaNot yet recruiting